IgA rheumatoid factor in primary Sjögren's syndrome

Scandinavian Journal of Rheumatology

Volumn 38, Issue 1, 2009, Pages 46-49

  Peen, E ^a   Mellbye, O J ^b   Haga, H J ^a,c  

^a AALBORG UNIVERSITY   (Denmark)

^b UNIVERSITY OF OSLO   (Norway)

^c Reumaklinik Danmark   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A RHEUMATOID FACTOR; IMMUNOGLOBULIN G; PROLACTIN; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY SJOEGREN SYNDROME; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SALIVARY GLAND BIOPSY; SJOEGREN SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; BIOPSY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROLACTIN; RHEUMATOID FACTOR; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 61649094265     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740802366043     Document Type: Article

References (25)

1. Jonsson R, Haga H-J, Gordon T. Sjögren's syndrome. In: Koopman WJ, editor. Arthritis and allied conditions - a textbook of rheumatology, 14th edn. Philadelphia: Lippincott Williams & Wilkins, 2001: 1736-59.
2. Manthorpe R, Bredberg A, Henriksson G, Larsson A. Progress and regression within Sjögren's syndrome. Scand J Rheumatol 2006;35:1-6.
3. Markusse HM, Otten HG, Vroom TM, Smeets TJ, Fokkens N, Breedveld FC. Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjögren's syndrome. Clin Immunol Immunopathol 1993;66:26-32.
4. Otten HG, Daha MR, van der Maarl MG, Hoogendoorn LI, Beem EM, de Rooy HH, et al. IgA rheumatoid factor in mucosal fluids and serum of patients with rheumatoid arthritis: immunological aspects and clinical significance. Clin Exp Immunol 1992;90:256-9.
5. Muller K, Oxholm P, Mier-Madsen M, Wiik A. Circulating IgA- and IgM-rheumatoid factors in patients with primary Sjögren syndrome. Correlation to extraglandular manifestations. Scand J Rheum 1989;18:29-31.
6. Elkon KB, Gharavi A, Hughes GRV, Moutsopoulos HM. Autoantibodies in the sicca syndrome (primary Sjögren's syndrome). Ann Rheum Dis 1984;43:243-5.
7. Atkinson JC, Travis WD, Slocum L, Ebbs WL, Fox PC. Serum anti-SS-B/La and IgA rheumatoid factor are markers of salivary gland disease activity in primary Sjögren's syndrome. Arthritis Rheum 1992;35:1368-72.
8. Jonsson T, Valdimarsson H. Clinical significance of rheumatoid factor isotypes in seropositive arthritis. Rheumatol Int 1992;12:111-13.
9. Jonsson T, Arinbjarnarson S, Thorsteinsson J, Steinsson K, Geirsson AJ, Jonsson H, et al. Raised IgA rheumatoid factor (RF) but not IgM RF or IgG RF is associated with extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 1995;24:372-5.
10. Teitsson I, Teitsson HM, Hernandez LA, Sturrock RD. IgA and IgM rheumatoid factors (RF) in established rheumatoid arthritis (RA): relationship to activity and radiological severity. Scand J Rheumatol 1986;Suppl 59:abstract F II 3::72.
11. Eberhardt KB, Truedsson L, Petterson H, Petterson H, Svensson B, Stigsson L, et al. Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor. Ann Rheum Dis 1990;49:906-9.
12. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Benavelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of an EEC prospective concerted action. Arthritis Rheum 1993;36:340-7.
13. Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sjögren's syndrome in labial salivary biopsies. Oral Surg 1974;37:217-29.
14. Kleveland G, Egeland T, Lea T. Quantitation of rheumatoid factor (RF) and IgM, IgA, and IgG isotypes by a simple and sensitive ELISA. Discrimination between false and true IgGRF. Scand J Rheumatol 1988;Suppl 75:15-24.
15. Daniels TE. Sjögren's syndrome: clinical spectrum and current diagnostic controversies. Adv Dent Res 1996;10:3-8.
16. Tengner P, Halse AK, Haga HJ, Jonsson R, Wahren-Herlenius M. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome. Arthritis Rheum 1998;41:2238-48.
17. Aaserod K, Haga HJ, Berg KJ, Hammerstrom J, Jorstad S. Renal involvement in primary Sjögren's syndrome. Q J Med 2000;93:297-304.
18. Shioji R, Furuyama T, Onodera S, Saito H, Ito H, Sosoki Y. Sjögren's syndrome and renal tubular acidosis. Am J Med 1970;48:456-63.
19. Gripenberg M, Teppo AM, Kurki P, Gripenberg G, Helve T. Autoantibody activity of cryoglobulins and sera in systemic lupus erythematosus. Scand J Rheum 1988;17:249-54.
20. Blackburn WD, Koopman WJ, Schrohenloher RE, Heck LW. Induction of neutrophil enzyme release by rheumatoid factors: evidence for differences based on molecular characteristics. Clin Immunol Immunopathol 1986;40:347-55.
21. Sabharwal UK, Vaughan JH, Fong S, Bennett PH, Carson DA, Curd JG. Activation of the classical pathway of complement by rheumatoid factors. Arthritis Rheum 1982;25:161-7.
22. Haga HJ, Rygh T. The prevalence of hyperprolactinemia in patients with primary Sjögren's syndrome. J Rheumatol 1999;26:1291-5.
23. Sabharwal P, Glaser R, Lafuse W, Varma S, Liu Q, Arkins S, et al. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci USA 1992;89:7713-16.
24. Neidhart M. Prolactin in autoimmune diseases. Proc Soc Exp Med 1998;217:899-906.
25. Haga H-J, Jonsson R. The influence of age on disease manifestations and serological characteristics in primary Sjögren's syndrome. Scand J Rheumatol 1999;28:227-32.